Heme arginate therapy enhanced adiponectin and atrial natriuretic peptide, but abated endothelin-1 with attenuation of kidney histopathological lesions in mineralocorticoid-induced hypertension

Journal of Pharmacology and Experimental Therapeutics

Volumn 334, Issue 1, 2010, Pages 87-98

  Ndisang, Joseph Fomusi ^a   Jadhav, Ashok ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; ADIPONECTIN; ARGININE; ATRIAL NATRIURETIC FACTOR; BILIRUBIN; CAPTOPRIL; CATALASE; CYCLIC GMP; ENDOTHELIN 1; FERRITIN; FIBRONECTIN; HEME ARGINATE; HEME OXYGENASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MESOPORPHYRIN; MINERALOCORTICOID; SPIRONOLACTONE; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTERIAL WALL THICKENING; ARTICLE; BLOOD PRESSURE; CELL SEPARATION; CONTROLLED STUDY; CREATININE CLEARANCE; ENZYME ACTIVITY; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HYPERTENSION; KIDNEY DISTAL TUBULE; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; KIDNEY INJURY; MALE; MONONUCLEAR CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; RENAL PROTECTION; UPREGULATION; WESTERN BLOTTING;

ADIPONECTIN; ANIMALS; ARGININE; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; BLOTTING, WESTERN; DESOXYCORTICOSTERONE; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; HEME; HEME OXYGENASE (DECYCLIZING); HYPERTENSION; KIDNEY; KIDNEY DISEASES; MALE; MINERALOCORTICOIDS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77953730770     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.164871     Document Type: Article

References (44)

1. Abraham NG and Kappas A (2008) Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 60:79-127.
2. Artunc F, Amann K, Nasir O, Friedrich B, Sandulache D, Jahovic N, Risler T, Vallon V, Wulff P, Kuhl D, et al. (2006) Blunted DOCA/high salt induced albuminuria and renal tubulointerstitial damage in gene-targeted mice lacking SGK1. J Mol Med 84:737-746.
3. Benigni A, Zoja C, Zatelli C, Corna D, Longaretti L, Rottoli D, Maggioni P, Todeschini M, Noris M, and Remuzzi G (2004) Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathy. Kidney Int 66:1959-1965.
4. Blasi ER, Rocha R, Rudolph AE, Blomme EA, Polly ML, and McMahon EG (2003) Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int 63:1791-1800.
5. Brown L, Duce B, Miric G, and Sernia C (1999) Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the reninangiotensin system. J Am Soc Nephrol 10 (Suppl 11):S143-S148.
6. Dietz JR (2005) Mechanisms of atrial natriuretic peptide secretion from the atrium. Cardiovasc Res 68:8-17.
7. Dworkin LD, Tolbert E, Recht PA, Hersch JC, Feiner H, and Levin RI (1996) Effects of amlodipine on glomerular filtration, growth, and injury in experimental hypertension. Hypertension 27:245-250. (Pubitemid 26045922)
8. Fenning A, Harrison G, Rose'meyer R, Hoey A, and Brown L (2005) L-Arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol 289:H1408-H1416.
9. Fiore G, Florio P, Micheli L, Nencini C, Rossi M, Cerretani D, Ambrosini G, Giorgi G, and Petraglia F (2005) Endothelin-1 triggers placental oxidative stress pathways: putative role in preeclampsia. J Clin Endocrinol Metab 90:4205-4210.
10. Folco EJ, Rocha VZ, López-Ilasaca M, and Libby P (2009) Adiponectin inhibits proinflammatory signaling in human macrophages independent of interleukin-10. J Biol Chem 284:25569-25575.
11. Fukunaga M, Yura T, and Badr KF (1995) Stimulatory effect of 8-Epi-PGF2́, an F2-isoprostane, on endothelin-1 release. J Cardiovasc Pharmacol 263 (Suppl 3):S51-S52.
12. Gimeno G, Carpentier PH, Desquand-Billiald S, Hanf R, and Finet M (1998) Histamine-induced biphasic macromolecular leakage in the microcirculation of the conscious hamster: evidence for a delayed nitric oxide-dependent leakage. Br J Pharmacol 123:943-951.
13. Iwazu Y, Muto S, Fujisawa G, Nakazawa E, Okada K, Ishibashi S, and Kusano E (2008) Spironolactone suppresses peritubular capillary loss and prevents deoxycorticosterone acetate/salt-induced tubulointerstitial fibrosis. Hypertension 51:749-754.
14. Jadhav A and Ndisang JF (2009) Heme arginate suppresses cardiac lesions and hypertrophy in deoxycorticosterone acetate-salt hypertension. Exp Biol Med (Maywood) 234:764-778.
15. Jadhav A, Torlakovic E, and Ndisang JF (2008) Interaction among heme oxygenase, nuclear factor-κB, and transcription activating factors in cardiac hypertrophy in hypertension. Hypertension 52:910-917.
16. Jadhav A, Torlakovic E, and Ndisang JF (2009) Hemin therapy attenuates kidney injury in deoxycorticosterone acetate-salt hypertensive rats. Am J Physiol Renal Physiol 296:F521-F534.
17. Janssen LJ (2001) Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 280:L1067-L1082.
18. Khanna A, Simoni J, and Wesson DE (2005) Endothelin-induced increased aldosterone activity mediates augmented distal nephron acidification as a result of dietary protein. J Am Soc Nephrol 16:1929-1935.
19. Klanke B, Cordasic N, Hartner A, Schmieder RE, Veelken R, and Hilgers KF (2008) Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension. Nephrol Dial Transplant 23:3456-3463.
20. Larivière R, Thibault G, and Schiffrin EL (1993) Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension 21:294-300. (Pubitemid 23065167)
21. Lee MJ, Feliers D, Mariappan MM, Sataranatarajan K, Mahimainathan L, Musi N, Foretz M, Viollet B, Weinberg JM, Choudhury GG, et al. (2007) A role for AMPactivated protein kinase in diabetes-induced renal hypertrophy. Am J Physiol Renal Physiol 292:F617-F627.
22. Lee SD, Lee DS, Chun YG, Paik SH, Kim WS, Kim DS, Kim WD, Tuder RM, and Voelkel NF (2000) Transforming growth factor-β1 induces endothelin-1 in a bovine pulmonary artery endothelial cell line and rat lungs via cAMP. Pulm Pharmacol Ther 13:257-265.
23. Levere RD, Martasek P, Escalante B, Schwartzman ML, and Abraham NG (1990) Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats. J Clin Invest 86:213-219.
24. Ndisang JF and Jadhav A (2010a) Heme arginate suppresses phospholipase C and oxidative stress in the mesenteric arterioles of mineralcorticoid-induced hypertensive rats. Hypertens Res 33:338-347.
25. Ndisang JF and Jadhav A (2010b) The heme oxygenase system attenuates pancreatic lesions and improves insulin sensitivity and glucose metabolism in deoxycorticosterone acetate hypertension. Am J Physiol Regul Integr Comp Physiol 298:R211-R223.
26. Ndisang JF, Lane N, and Jadhav A (2008) Crosstalk between the heme oxygenase system, aldosterone, and phospholipase C in hypertension. J Hypertens 26:1188-1199.
27. Ndisang JF, Lane N, and Jadhav A (2009) The heme oxygenase system abates hyperglycemia in Zucker diabetic fatty rats by potentiating insulin-sensitizing pathways. Endocrinology 150:2098-2108.
28. Ndisang JF, Lane N, Syed N, and Jadhav A (2010) Up-regulating the heme oxygenase system with hemin improves insulin sensitivity and glucose metabolism in adult spontaneously hypertensive rats. Endocrinology 151:549-560.
29. Ohta K, Yachie A, Fujimoto K, Kaneda H, Wada T, Toma T, Seno A, Kasahara Y, Yokoyama H, Seki H, et al. (2000) Tubular injury as a cardinal pathologic feature in human heme oxygenase-1 deficiency. Am J Kidney Dis 35:863-870.
30. Ortmann J, Amann K, Brandes RP, Kretzler M, Münter K, Parekh N, Traupe T, Lange M, Lattmann T, and Barton M (2004) Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition. Hypertension 44:974-981.
31. Pandey KN (2005) Biology of natriuretic peptides and their receptors. Peptides 26:901-932.
32. Piechota M, Banach M, Irzmański R, Misztal M, Rysz J, Barylski M, Piechota-Urbańska M, Kowalski J, and Pawlicki L (2007) N-terminal brain natriuretic propeptide levels correlate with procalcitonin and C-reactive protein levels in septic patients. Cell Mol Biol Lett 12:162-175.
33. Pryor WA and Squadrito GL (1995) The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol Lung Cell Mol Physiol 268:L699-L722.
34. Riba R, Patel B, Aburima A, and Naseem KM (2008) Globular adiponectin increases cGMP formation in blood platelets independently of nitric oxide. J Thromb Haemost 6:2121-2131.
35. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, et al. (2008) Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117:e25-146.
36. Rosón MI, Toblli JE, Della Penna SL, Gorzalczany S, Pandolfo M, Cavallero S, and Fernández BE (2006) Renal protective role of atrial natriuretic peptide in acute sodium overload-induced inflammatory response. Am J Nephrol 26:590-601.
37. Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR, Ouedraogo R, Hough K, McCue P, Chan L, et al. (2008) Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 118:1645-1656.
38. Shi-wen X, Kennedy L, Renzoni EA, Bou-Gharios G, du Bois RM, Black CM, Denton CP, Abraham DJ, and Leask A (2007) Endothelin is a downstream mediator of profibrotic responses to transforming growth factor β in human lung fibroblasts. Arthritis Rheum 56:4189-4194.
39. Stanford SJ, Walters MJ, and Mitchell JA (2004) Carbon monoxide inhibits endothelin-1 release by human pulmonary artery smooth muscle cells. Eur J Pharmacol 486:349-352.
40. Tanaka T, Tsutamoto T, Sakai H, Nishiyama K, Fujii M, Yamamoto T, and Horie M (2008) Effect of atrial natriuretic peptide on adiponectin in patients with heart failure. Eur J Heart Fail 10:360-366.
41. Tsukamoto O, Fujita M, Kato M, Yamazaki S, Asano Y, Ogai A, Okazaki H, Asai M, Nagamachi Y, Maeda N, et al. (2009) Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure. J Am Coll Cardiol 53:2070-2077.
42. U.S. Renal Data Systems (2007) U.S. Renal Data System 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
43. Wang Y, Krämer S, Loof T, Martini S, Kron S, Kawachi H, Shimizu F, Neumayer HH, and Peters H (2005) Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis. Kidney Int 68:47-61.
44. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288-1295.